Nightmares in Midlife May Point to Future Cognitive Decline, Dementia
By Lori Solomon HealthDay Reporter
FRIDAY, July 12, 2024 -- Distressing dreams in middle-aged and older adults may indicate a higher risk for future cognitive decline and all-cause dementia, according to a study presented at EAN 2024, the 10th Congress of the European Academy of Neurology, held from June 29 to July 2 in Helsinki.
Abidemi Otaiku, M.D., from Imperial College London, and colleagues examined whether distressing dreams are associated with cognitive decline and dementia in people without Parkinson disease. The analysis included 605 middle-aged adults from the Midlife in the United States study who were followed for more than 13 years, as well as 2,600 older adults from the Osteoporotic Fractures in Men Study and the Study of Osteoporotic Fractures, followed for more than seven years.
The researchers found that compared with middle-aged adults who reported having no distressing dreams at baseline, those who reported having weekly distressing dreams had a fourfold higher risk for experiencing cognitive decline (adjusted odds ratio, 3.99). Dementia risk more than doubled in older adults (adjusted odds ratio, 2.21).
"Nightmares have a very strong link with many brain and other conditions, and I strongly believe that nightmares should be asked about more often by physicians," Otaiku said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Moderately Preterm Birth Tied to Long-Term Cognitive Problems
FRIDAY, April 25, 2025 -- Moderately preterm birth is associated with cognitive problems at ages 9 to 10 years, according to a study published online April 14 in JAMA Network...
Metabolic Syndrome Linked to Increased Risk for Young-Onset Dementia
THURSDAY, April 24, 2025 -- Metabolic syndrome (MetS) and its individual components are associated with an increased risk for young-onset dementia (YOD), according to a study...
Dementia Biomarkers Associated With Age, Sex, APOE ε4 Status
MONDAY, April 21, 2025 -- Dementia biomarkers -- phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) -- are associated with age...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.